Quick Answer
Protagenic Therapeutics, Inc.new reported Net Income of -$5.53 million for fiscal year 2024.
Protagenic Therapeutics, Inc.new Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$5.53M | -10.5% |
| 2023 | -$5.00M | -40.6% |
| 2022 | -$3.56M | +21.4% |
| 2021 | -$4.52M | -77.5% |
| 2020 | -$2.55M | -45.6% |
| 2019 | -$1.75M | +31.5% |
| 2018 | -$2.56M | -13.2% |
| 2017 | -$2.26M | +0.7% |
| 2016 | -$2.28M | -122.4% |
| 2015 | -$1.02M | -115.0% |
| 2015 | -$476.0K | +55.9% |
| 2014 | -$1.08M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $2.21M | +360.0% | +354.3% |
| September 30, 2025 | -$869.5K | -49.3% | +82.8% |
| June 30, 2025 | -$5.06M | -1459.3% | -251.2% |
| March 31, 2025 | -$1.44M | +16.5% | -69.4% |
| December 31, 2024 | -$850.3K | — | -46.0% |
| September 30, 2024 | -$582.4K | +58.3% | -79.6% |
| June 30, 2024 | -$324.4K | +73.2% | +81.2% |
| March 31, 2024 | -$1.72M | -140.1% | -23.5% |
- Protagenic Therapeutics, Inc.new showed a decrease of -10.5% in Net Income compared to the prior fiscal year.
- Over the 2014–2024 period, Protagenic Therapeutics, Inc.new’s net income has declined by 412.1% (from -$1.08 million to -$5.53 million).
- The most recent figure is from Protagenic Therapeutics, Inc.new’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: